Changes in Myocardial Iron Content Following Administration of Intravenous Iron

Trial Profile

Changes in Myocardial Iron Content Following Administration of Intravenous Iron

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Acronyms Myocardial-IRON
  • Most Recent Events

    • 28 Jul 2018 Status changed from recruiting to completed.
    • 01 Apr 2018 The results will be available around October 2018.
    • 01 Apr 2018 Patient enrollment started in May 2017. Till 31 December 2017, 25 patients were enrolled in the study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top